Back to search
Post-Menopausal Osteoporosis
Clinical trial pipeline · Data from ClinicalTrials.gov
See which Post-Menopausal Osteoporosis trials you may qualify forClinical trial pipeline · Data from ClinicalTrials.gov
See which Post-Menopausal Osteoporosis trials you may qualify forDuring menopause, estrogen levels drop while the level of another hormone - LH (luteinizing hormone) substantially increases. This hormonal shift is linked to b…
Denosumab (Dmab) is a treatment for postmenopausal osteoporosis. However, its withdrawal is associated with a rebound phenomenon associated with an unexpected i…
This study aims to evaluate the adherence of patients to combined treatment with bisphosphonates and calcium and vitamin D supplements, which is one of the usua…
Post-menopausal osteoporosis and the resulting fractures are an important cause of disability and loss of independence. They also increase the risk of morbidity…
This study will be conducted to determine the effect of circuit training on bone mineral density in post menopausal period.
12-month prospective, open-label, multicenter, international, observational study evaluating sequential treatments after osteoanabolics
The goal of this clinical trial is to learn if romosozumab (Evenity) can improve bone and muscle health in postmenopausal women with osteoporosis who are underg…
This study is a prospective, multicenter, open-label, randomized non-inferiority trial comparing intravenous ibandronate and zoledronic acid as sequential thera…
The primary objective of this study is to evaluate the safety and tolerability of human umbilical cord-derived mesenchymal stem cells for injection (HMM910 ) in…